The Fool Looks Ahead

There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.

Monday
The new trading week kicks off with Peregrine Pharmaceuticals (NASDAQ: PPHM  ) posting its latest quarterly results.

The biotech has been one of the market's most volatile stocks. It got crushed in September, when it revealed that initially upbeat data from a clinical trial for its non-small-cell lung cancer drug was mishandled and inaccurate.

Peregrine bounced back last month, though naturally it's expected to post another quarterly loss on Monday.

Tuesday
Geospace Technologies (NASDAQ: GEOS  ) reports on Tuesday.The maker of gear used by the oil and gas industry in the acquisition and processing of seismic data is expected to post a profit of $0.66 a share in its fiscal fourth quarter, more than doubling the $0.28 it delivered a year earlier.

Wednesday
Joy Global (NYSE: JOY  ) and Avanir Pharmaceuticals (NASDAQ: AVNR  ) report on Wednesday. The two companies have little in common. Joy Global sells mining equipment. Avanir is a biotech focusing on the treatment of central nervous system disorders. However, both companies are expected to post bottom-line improvements since the same period a year earlier.

Thursday
Southcross Energy Partners
(NYSE: SXE  ) streams in on Thursday. The owner of natural-gas pipelines and a player in the liquefied-natural-gas market just went public last month at $20. It will now be posting its first quarterly report as a public company.

Friday
The final trading day of the week will be quiet on the earnings front, but that will only give traders time to head out to the local multiplex to catch The Hobbit: An Unexpected Journey. Peter Jackson is back at the helm after his globally successful Lord of the Rings trilogy.

Check that calendar
If you like to stay on top of what happens next -- and I'm guessing you do, because you're reading this article -- how about checking out a new report identifying the one energy stock that you must own before 2014? Yes, 2014. It's a free report, but only for a limited time, so click here to check it out now.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 12, 2012, at 10:19 AM, hanover67 wrote:

    GEOS expected EPS $.66, actual $.33. Where was the guidance on this from the company?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2145361, ~/Articles/ArticleHandler.aspx, 10/20/2014 4:35:41 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement